Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,761,088
+$644,698 QoQ
Shares Held
2,302
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,201
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Telos Capital Management, Inc. holds $41,593,885 across 9 Drug Manufacturers - General names. LLY ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,049 | $11,695,064 | |
| 2 | AMGN |
Amgen Inc
|
25,990 | $9,411,498 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
111,780 | $6,440,763 | |
| 4 | ABBV |
AbbVie Inc.
|
18,380 | $4,625,143 | |
| 5 | NVS |
Novartis AG
|
25,483 | $3,993,695 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
2,302 | $2,761,088 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,035 | $1,803,497 | |
| 8 | PFE |
Pfizer Inc
|
25,954 | $624,972 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,761,088 | 2,302 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,116,390 | 2,301 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $2,505,079 | 2,331 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,896,055 | 2,485 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,556,858 | 3,280 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,636,953 | 1,982 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,533,964 | 1,987 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,431,679 | 1,616 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,463,094 | 1,616 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,311,640 | 1,686 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,229,959 | 5,541 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,062,178 | 5,701 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,673,654 | 5,701 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,012,441 | 5,860 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,145,651 | 5,865 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,953,680 | 6,042 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $2,323,756 | 7,167 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,052,413 | 7,167 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,007,290 | 7,267 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,702,145 | 7,367 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,690,873 | 7,367 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,700,435 | 9,102 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,509,767 | 8,942 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,317,674 | 8,902 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,461,530 | 8,902 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,241,821 | 8,952 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||